Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CDI Market Snapshot: Microbiome Therapies Begin Descent On Landscape

Dec 19 2022

• By David Wild

Microbiome Treatments Come Of Age • Source: Shutterstock

Related Content

Ferring’s Fecal Transplant Gets Through AdComm, Aided By Preference For Standardized Product

Sep 23 2022

New FDA Fecal Transplant Guidance Should Ease Ferring’s Path To Commercialization

Nov 29 2022

Ferring Favorite To Get First Approval For Microbiota-Based Therapy

Jul 08 2019

Seres Banks Serious Cash To Drive Microbiome Therapy To Market

Jul 02 2021

Ferring Makes Important Milestone For Microbiome With Rebyota Approval

Dec 01 2022

Related Companies

Ferring Pharmaceuticals

Merck & Co., Inc.

Rebiotix, Inc.

Seres Therapeutics, Inc.

Finch Therapeutics Group, Inc.

Vedanta Biosciences, Inc.

Destiny Pharma plc

Additional Topics

Market Intelligence Launches Research & Development Regulation Regenerative Medicine FDA Innovation Market Snapshot Gastrointestinal BioPharmaceutical

More from Market Intelligence

More from In Vivo

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.